XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based compensation (Tables)
9 Months Ended
Sep. 30, 2023
Stock-based compensation  
Compensation cost recognized for all stock-based compensation awards

Three Months Ended

Nine Months Ended

September 30, 

 

September 30, 

 

    

2023

    

2022

 

2023

    

2022

 

(in thousands)

 

Research and development

$

919

$

588

$

2,472

$

2,170

General and administrative

 

1,959

 

1,601

 

5,636

 

4,828

Total stock-based compensation expense

$

2,878

$

2,189

$

8,108

$

6,998

Summary of stock-based compensation expense by type of award

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

2023

    

2022

(in thousands)

Stock options

$

2,021

$

1,357

$

5,587

$

4,452

Restricted stock awards and units

774

748

2,339

2,382

Employee stock purchase plan awards

 

83

 

84

182

164

Total stock-based compensation expense

$

2,878

$

2,189

$

8,108

$

6,998

Summary of status and changes in unvested restricted stock

    

    

Weighted

Average

Grant Date

Fair Value

    

Units

    

Per Unit

Unvested restricted stock units as of December 31, 2022

 

1,112,563

$

5.27

Granted

 

725,550

$

7.52

Vested

 

(459,745)

$

5.68

Forfeited

 

(65,641)

$

4.65

Unvested restricted stock units as of September 30, 2023

 

1,312,727

$

6.40

Summary of stock option activity

    

    

Weighted

    

Remaining

    

Aggregate

Average

Contractual

Intrinsic

Exercise

Life

Value

    

Shares

    

Price

    

(in years)

    

(in thousands)

Outstanding at December 31, 2022

 

6,199,571

$

8.12

7.9

$

6,095

Granted

 

2,250,400

$

8.64

Exercised

 

(377,593)

$

5.02

Cancelled or forfeited

 

(326,785)

$

9.60

Outstanding at September 30, 2023

 

7,745,593

$

8.42

 

7.9

$

9,348

Exercisable at September 30, 2023

 

3,527,536

$

9.66

 

6.7

$

4,355